Report Back From SABCS 2024: What’s the Latest in MBC
Diagnosis and Treatment, Novel Treatments, Clinical Research Our MBClife Diagnosis and Treatment, Novel Treatments, Clinical Research Our MBClife

Report Back From SABCS 2024: What’s the Latest in MBC

Welcome to our Season 10 opening episode! Today we’re discussing some of the big updates in metastatic breast cancer research from the 2024 San Antonio Breast Cancer Symposium (SABCS). Joining us today is Dr. Debu Tripathy, breast oncologist at The University of Texas MD Anderson Cancer Center who will break down into understandable terms some of the most impactful findings shared at SABCS, from advances in endocrine therapy and HER2-targeted treatments to exciting developments in PI3K inhibition and nausea control.

Read More
Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer
Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife

Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer

Are you living with ER+/HER2- or TNBC MBC and tired of hearing about new HER2 therapies and wondering when it will be your turn? Just after the meeting SHARE welcomed Dr. Timothy Pluard from University of Missouri-KC School of Medicine to a webinar highlighting promising data from trials and labs across the globe presented at the this year’s meeting,

Read More